| Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial). | |
| | |
MedLine Citation:
|
PMID: 15721102 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
White blood cell (WBC) count and temperature are 2 global measures of inflammation that are systematically gathered and easily identifiable in a clinical setting, unlike many other markers of inflammation being investigated in patients with coronary artery disease. The prognostic usefulness of the WBC count and temperature were evaluated in a large acute myocardial infarction trial, the Complement And ReDuction of INfarct size after Angioplasty or Lytics program. Baseline and serial measurements of WBC counts and temperature were correlated with infarct size and clinical outcome. |
| | |
Authors:
|
Manesh R Patel; Kenneth W Mahaffey; Paul W Armstrong; W Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rollins; Pierre Theroux; Witold Ruzyllo; Jose C Nicolau; Christopher B Granger; |
Publication Detail:
|
Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: The American journal of cardiology Volume: 95 ISSN: 0002-9149 ISO Abbreviation: Am. J. Cardiol. Publication Date: 2005 Mar |
Date Detail:
|
Created Date: 2005-02-21 Completed Date: 2005-03-24 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 614-8 Citation Subset: AIM; IM |
Affiliation:
|
Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty Antibodies, Monoclonal / therapeutic use Area Under Curve Body Temperature* Chi-Square Distribution Creatine Kinase / blood Humans Leukocyte Count* Linear Models Myocardial Infarction / immunology*, mortality, therapy Predictive Value of Tests Prognosis Survival Analysis Thrombolytic Therapy |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/h5G1.1-scFv; EC 2.7.3.2/Creatine Kinase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor t...
Next Document: Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent...